Hepatocyte growth factor facilitates the repair of large colonic ulcers in 2,4,6-trinitrobenzene sulfonic acid-induced colitis in rats

Inflammatory Bowel Diseases

Volumn 11, Issue 6, 2005, Pages 551-558

  Numata, Masatsugu ^a,b   Ido, Akio ^b   Moriuchi, Akihiro ^b   Kim, Ildeok ^b   Tahara, Yoshihiro ^a   Yamamoto, Shojiro ^a   Hasuike, Satoru ^a   Nagata, Kenji ^a   Miyata, Yoshifumi ^a   Uto, Hirofumi ^a   Tsubouchi, Hirohito ^a,b  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

2,4,6 trinitrobenzene sulfonic acid; Hepatocyte growth factor; Inflammatory bowel disease; Mucosal injury; Mucosal repair

Indexed keywords

MYELOPEROXIDASE; PHOSPHATE BUFFERED SALINE; RECOMBINANT SCATTER FACTOR; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOLUS INJECTION; CELL INFILTRATION; CELL MIGRATION; COLITIS; COLON ULCER; CONTROLLED STUDY; DRUG EFFECT; ENTERITIS; ENZYME ACTIVITY; ENZYME ASSAY; GASTROINTESTINAL ENDOSCOPY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INFLAMMATORY CELL; INTESTINE EPITHELIUM CELL; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ULCER HEALING; WOUND HEALING;

ANIMALS; CELL PROLIFERATION; COLONIC DISEASES; HEPATOCYTE GROWTH FACTOR; MALE; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; TRINITROBENZENESULFONIC ACID; ULCER; WOUND HEALING;

EID: 20444441872     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MIB.0000164192.71381.5c     Document Type: Article

References (37)

1. Murphy MS. Growth factors and the gastrointestinal tract. Nutrition. 1998;14:771-774.
2. Beck PL, Podolsky DK. Growth factors in inflammatory bowel disease. Inflamm Bowel Dis. 1999;5:44-60.
3. Dignass AU, Sturm A. Peptide growth factors in the intestine. Eur J Gastroenterol Hepatol. 2001;13:763-770.
4. Gohda E, Tsubouchi H, Nakayama H, et al. Human hepatocyte growth factor in plasma from patients with fulminant hepatic failure. Exp Cell Res. 1986;166:139-150.
5. Gohda E, Tsubouchi H, Nakayama H, et al. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest. 1988;81:414-419.
6. Igawa T, Kanda S, Kanetake H, et al. Hepatocyte growth factor is a potent mitogen for cultured rabbit renal tubular epithelial cells. Biochem Biophys Res Commun. 1991;174:831-838.
7. Joplin R, Hishida T, Tsubouchi H, et al. Human intrahepatic biliary epithelial cells proliferate in vitro in response to human hepatocyte growth factor. J Clin Invest. 1992;90:1284-1289.
8. Takahashi M, Ota S, Terano A, et al. Hepatocyte growth factor induces mitogenic reaction to the rabbit gastric epithelial cells in primary culture. Biochem Biophys Res Commun. 1993;19:528-534.
9. Dignass AU, Lynch-Devaney K, Podolsky K. Hepatocyte growth factor/scatter factor modulates intestinal epithelial cell proliferation and migration. Biochem Biophys Res Commun. 1994;202:701-709.
10. Weidner KM, Sachs M, Birchmeier W. The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells. J Cell Biol. 1993;121: 145-154.
11. Kitamura S, Kondo S, Shimomura Y, et al. Expression of hepatocyte growth factor and c-met in ulcerative colitis. Inflamm Res. 2000;49:320-324.
12. Matsuo M, Shiota G, Umeki K, et al. Induction of plasma hepatocyte growth factor in acute colitis of mice. Inflamm Res. 1997;46:166-167.
13. Ortega-Cava CF, Ishihara S, Kawashima K, et al. Hepatocyte growth factor expression in dextran sodium sulfate-induced colitis in rats. Dig Dis Sci. 2002;47:2275-2285.
14. Itoh H, Kataoka H, Tomita M, et al. Upregulation of HGF activator inhibitor type 1 but not type 2 along with regeneration of intestinal mucosa. Am J Physiol Gastrointest Liver Physiol. 2000;278:G635-G643.
15. Kataoka H, Shimomura T, Kawaguchi T, et al. Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironment. J Biol Chem. 2000;275: 40453-40462.
16. Hanauer SB, Present DH. The state of the art in the management of inflammatory bowel disease. Rev Gastroenterol Disord. 2003;3:81-92.
17. Sandborn WJ, Hanauer SB. Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety. Inflamm Bowel Dis. 1999;5:119-133.
18. Tahara Y, Ido A, Yamamoto S, et al. Hepatocyte growth factor facilitates colonic mucosal repair in experimental ulcerative colitis in rats. J Pharm Exp Therap. 2003;307:146-151.
19. Ido A, Moriuchi A, Kim IL, et al. Pharmacokinetic study of recombinant human hepatocyte growth factor administered in a bolus intravenously or via portal vein. Hepatol Res. 2004;30:175-181.
20. Stucchi AF, Shofer S, Leeman S, et al. NK-1 antagonist reduces colonic inflammation and oxidative stress in dextran sulfate-induced colitis in rats. Am J Physiol Gastrointest Liver Physiol. 2000;279:G1298-G1306.
21. Macpherson BR, Pfeiffer CJ. Experimental production of diffuse colitis in rats. Digestion. 1978;17:135-150.
22. Tsune I, Ikejima K, Hirose M, et al. Dietary glycine prevents chemical-induced experimental colitis in the rat. Gastroenterology. 2003;125:775-785.
23. Bradley PP, Priebat DA, Christensen RD, et al. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982;78:206-209.
24. Moreels TG, Nieuwendijk RJ, De Man JG, et al. Concurrent infection with Schistosoma mansoni attenuates inflammation induced changes in colonic morphology, cytokine levels, and smooth muscle contractility of trinitrobenzene sulphonic acid induced colitis in rats. Gut. 2004;53:99-107.
25. Hibi T, Ogata H, Sakuraba A. Animal models of inflammatory bowel disease. J Gastroenterol. 2002;37:409-417.
26. Neurath MF, Fuss I, Kelsall BL, et al. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med. 1995;182: 1281-1290.
27. Ahn BK, Ko KH, Oh TY, et al. Efficacy of use of colonoscopy in dextran sulfate sodium induced ulcerative colitis in rats: the evaluation of the effects of antioxidant by colonoscopy. Int J Colorectal Dis. 2001;16:174-181.
28. Huang EH, Carter JJ, Whelan RL, et al. Colonoscopy in mice. Surg Enclose. 2002;16:22-24.
29. Nusrat A, Parkos CA, Bacarra AE, et al. Hepatocyte growth factor/scatter factor effects on epithelia. Regulation of intercellular junctions in transformed and nontransformed cell lines, basolateral polarization of c-met receptor in transformed and natural intestinal epithelia, and induction of rapid wound repair in a transformed model epithelium. J Clin Invest. 1994; 93:2056-2065.
30. Mammen JMV, Matthews JB. Mucosal repair in the gastrointestinal tract. Crit Care Med. 2003;31(Suppl):S532-S537.
31. Grant DS, Kleinman HK, Goldberg ID, et al. Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA. 1993;90:1937-1941.
32. Goke M, Kanai M, Podolsky DK. Intestinal fibroblast regulate intestinal epithelial cell proliferation via hepatocyte growth factor. Am J Physiol Gastrointest Liver Physiol. 1998;274:G809-G818.
33. Hori T, Ido A, Uto H, et al. Activation of hepatocyte growth factor in monkey stomach following gastric mucosal injury. J Gastroenterol. 2004;39: 133-139.
34. Grenier A, Chollet-Martin S, Crestani B, et al. Presence of a mobilizable intracellular pool of hepatocyte growth factor in human polymorphonuclear neutrophils. Blood. 2002;99:2997-3004.
35. Adams DH, Harvath L, Bottaro DR et al. Hepatocyte growth factor and macrophage inflammatory protein 1b: Structurally distinct cytokines that induce rapid cytoskeletal changes and subset-preferential migration in T cells. Proc Natl Acad Sci USA. 1994;91:7144-7148.
36. Mine S, Tanaka Y, Suematu M, et al. Hepatocyte growth factor is a potent trigger of neutrophil adhesion through rapid activation of lymphocyte function-associated antigen-1. Lab Invest. 1998;78:1395-1404.
37. Beilmann M, Vande Woude GF, Dienes HP, et al. Hepatocyte growth factor-stimulated invasiveness of monocytes. Blood. 2000;95: 3964-3969.